To address whether RASA1 expression is associated with clinical outcome of melanoma patients, we examined the association between RASA1 expression level and overall survival in a historical cohort of 253 metastatic melanoma samples collected at the Moffitt Cancer Center under the Total Cancer Care (TCC) project. Here, RASA1 is linked to melanoma.